Physician profile
Dennis E Hanney
NPI 1669411484
$1,083.19
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $152 · 2021: $177 · 2022: $189 · 2023: $259 · 2024: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $238.96 | 2023-2024 | Qdot Micro Catheter, Carto 3 |
| Novo Nordisk INC | $212.44 | 2019-2023 | Rybelsus, Ozempic |
| Medtronic Vascular, INC. | $137.02 | 2020 | |
| Impulse Dynamics (USA) INC. | $132.49 | 2021 | |
| Dynasplint Systems INC. | $94.05 | 2022 | |
| Glaxosmithkline, LLC. | $70.50 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Boston Scientific Corporation | $35.23 | 2023 | Watchman Access System |
| Amarin Pharma, INC. | $23.97 | 2019 | |
| Abbott Laboratories | $21.17 | 2023 | Freestyle Libre 3 |
| Exact Sciences Corporation | $20.31 | 2024 | Cologuard Collection Kit |
| Seqirus USA INC | $19.83 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.79 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.77 | 2023 | Trintellix |
| Janssen Pharmaceuticals, INC | $16.59 | 2019 | |
| Medline Industries Lp | $13.76 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.31 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Hanney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.